Foreign body reaction triggered by cytotoxic T lymphocyte-associated protein 4 blockade 25 years after dermal filler injection
- 24 September 2016
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 175 (6), 1351-1353
- https://doi.org/10.1111/bjd.14674
Abstract
Foreign body reactions are regularly seen as a late complication of cosmetic treatment with synthetic dermal fillers. Often this foreign body reaction is triggered by a systemic infection, but other systemic triggers are reported in literature as well. In this case report, we present a female patient in her 60s who was treated with ipilimumab for metastatic melanoma. After two courses of treatment she developed painless facial nodules. A foreign body reaction to dermal fillers was suspected because patient had received cosmetic treatment with dermal fillers 25 years before. This was confirmed by excision and histological examination. In the absence of other known triggers, this case report revealed immunotherapy (ipilimumab) and subsequent activation of the adaptive immune-system, as potential trigger of foreign body reactions to dermal fillers. Immunotherapy is increasingly used as anti-cancer treatment for an increasing number of tumour types. Furthermore, synthetic dermal fillers were frequently used in the past. Therefore physicians should be aware of this late-occurring complication of synthetic filler treatment in patients that develop skin lesions during treatment with immunotherapy. This article is protected by copyright. All rights reserved.Keywords
This publication has 12 references indexed in Scilit:
- Patient factors influencing dermal filler complications: prevention, assessment, and treatmentClinical, Cosmetic and Investigational Dermatology, 2015
- Foreign Body Granulomas after the Use of Dermal Fillers: Pathophysiology, Clinical Appearance, Histologic Features, and TreatmentArchives of Plastic Surgery, 2015
- Injectable Fillers: Review of Material and PropertiesFacial Plastic Surgery, 2015
- Management of Immune-Related Adverse Events and Kinetics of Response With IpilimumabJournal of Clinical Oncology, 2012
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic MelanomaNew England Journal of Medicine, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Foreign Body Granulomas after All Injectable Dermal Fillers: Part 2. Treatment OptionsPlastic and Reconstructive Surgery, 2009
- Foreign Body Granulomas after All Injectable Dermal Fillers: Part 1. Possible CausesPlastic and Reconstructive Surgery, 2009
- Adverse reactions to dermal fillers: A review of European experiencesJournal of Cosmetic and Laser Therapy, 2005
- Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4Immunity, 1995